Strata Skin Sciences (SSKN) Trading Up 1.4%

Strata Skin Sciences, Inc. (NASDAQ:SSKN) shares were up 1.4% on Wednesday . The stock traded as high as $1.57 and last traded at $1.42. Approximately 25,433 shares changed hands during trading, a decline of 84% from the average daily volume of 162,417 shares. The stock had previously closed at $1.40.

Several research analysts have recently weighed in on SSKN shares. HC Wainwright reissued a “buy” rating and set a $7.00 price target on shares of Strata Skin Sciences in a research report on Friday, November 10th. Zacks Investment Research raised shares of Strata Skin Sciences from a “sell” rating to a “hold” rating in a research report on Thursday. Finally, ValuEngine cut shares of Strata Skin Sciences from a “sell” rating to a “strong sell” rating in a research report on Sunday, December 31st.

The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.07 and a current ratio of 1.64. The company has a market capitalization of $5.95, a PE ratio of -0.24 and a beta of 0.41.

WARNING: This news story was published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this news story on another site, it was stolen and reposted in violation of U.S. & international copyright laws. The correct version of this news story can be read at https://www.com-unik.info/2018/01/12/strata-skin-sciences-sskn-trading-up-1-4.html.

Strata Skin Sciences Company Profile

STRATA Skin Sciences, Inc, formerly MELA Sciences, Inc, is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging.

Receive News & Ratings for Strata Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit